AIM ImmunoTech (AIM) Refutes Activist Group’s False and Misleading Claims
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Marvell shares jump after giving Google warrants amid custom chip deal
AIM ImmunoTech Refutes Activist Group’s False and Misleading Claims
November 27, 2024 3:30 PM ESTSets Record Straight on Mischaracterization of AIMs Historical Share Price
Reminds AIM Shareholders of Activist Groups Numerous Lies, Omissions and Misrepresentations in Multi-Year Effort to Take Control of the Board
Urges Shareholders to Safeguard AIM by Voting FOR ALL Four of the Boards Incumbent Candidates and Discarding Any Proxy Materials Received from the Activist Group
OCALA, Fla.--(BUSINESS WIRE)-- AIM ImmunoTech Inc. (NYSE American: AIM) (AIM or the Company) today issued the following statement refuting the false and misleading claims... More
